Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer

BACKGROUND: SPRED1 and 2 are key negative regulators of MAPK signalling in mammalian cells. Here, we investigate the expression and functional role of SPREDs in prostate cancer. METHODS: A transcriptome bank of microdissected grade-specific primary cancers was constructed and interrogated for transc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kachroo, N, Valencia, T, Warren, A Y, Gnanapragasam, V J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593530/
https://www.ncbi.nlm.nih.gov/pubmed/23169297
http://dx.doi.org/10.1038/bjc.2012.507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593530/
https://www.ncbi.nlm.nih.gov/pubmed/23169297
http://dx.doi.org/10.1038/bjc.2012.507

Ejemplares similares